1 / 6

Acute Respiratory Distress Syndrome (ARDS) Market

The researcher assessing the Acute Respiratory Distress Syndrome (ARDS) Market dive deep to unearth intangible facts related to the key restraints, opportunities, and threats expected to shape the progress of the industry during the forecast period, 2020 - 2027.

thomasburnsrnd
Télécharger la présentation

Acute Respiratory Distress Syndrome (ARDS) Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Acute Respiratory Distress Syndrome (ARDS) Market To Reach USD 934.8 Million By 2026

  2. Market Summary Market Size – USD 583.8 Million in 2018, Market Growth - CAGR of 6.0% for the year 2026, Market trends – Increasing lung injuries due to car accidents with various chronic diseases such as pulmonary or systemic infection, neurological conditions, among others. According to the analysis of Reports and Data, the global acute respiratory distress syndrome market was valued at USD 583.8 Million in 2018 and is expected to reach USD 934.8 Million by the year 2026, at a CAGR of 6.0%. Acute respiratory distress syndrome (ARDS) is a type of respiratory failure, which is a form of lung inflammation. • Further key findings from the report suggest • The market for acute respiratory distress syndrome is anticipated to grow at a CAGR of 8.3% in the Asia-Pacific, followed by North America and Europe, with 4.8% and 5.7% CAGR, respectively. Increasing chronic diseases and the rise in air pollution are the key factors to accelerate market growth during the forecast period across all regions. • As of 2018, the therapeutic device segment was valued at USD 291.9 Million and is expected to grow at a CAGR of 5.8% during the forecast period. Increasing preference for gastrointestinal bleeding and pulmonary fibrosis has been one of the reasons for the growth of the acute respiratory distress syndrome market. • Due to the ARDS, various complications related to the brain and lung are noticed. Neurological hypoxic brain damage is also one of the injury types, which is reported for acute respiratory distress syndrome. www.reportsanddata.com

  3. Market Summary Key Players: Key participants include Faron Pharmaceuticals, BioMarck Pharmaceuticals, GE Healthcare, Hamilton Medical AG, Smiths Medical, Athersys, GlaxoSmithKline, Altor Bioscience, and Mondobiotech. Segmentation: Injury Type (Revenue in USD Million; Volume in Tons, 2016–2026) Brain Injury Lung Injury Severity (Revenue in USD Million; Volume in Tons, 2016–2026) Mild Moderate Severe To look at the PDF Sample Report and get 30 minutes of a free consultation @ https://www.reportsanddata.com/sample-enquiry-form/2089 www.reportsanddata.com

  4. Market Summary Treatment (Revenue in USD Million; Volume in Tons, 2016–2026) Fibro Proliferate Exudative Stage Resolution Stage Recovery Stage Regional Outlook (Revenue, USD Million; 2016-2026) North America U.S. Europe France UK Asia Pacific China India Japan Latin America Brazil MEA Grab Your Report at an Impressive Discount! Please Click Here : @ https://www.reportsanddata.com/discount-enquiry-form/2089 www.reportsanddata.com

  5. The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes? Q.4.Which factors are impacting the future of the market and what are the driving factors? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period? www.reportsanddata.com

  6. About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related